A099190 Stock Overview
Engages in the development, manufacture, and sale of chemical and biosensors in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A099190 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
i-SENS, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩18,550.00 |
| 52 Week High | ₩23,750.00 |
| 52 Week Low | ₩14,520.00 |
| Beta | 0.79 |
| 1 Month Change | 15.79% |
| 3 Month Change | 1.37% |
| 1 Year Change | -12.09% |
| 3 Year Change | 37.41% |
| 5 Year Change | 59.91% |
| Change since IPO | 114.45% |
Recent News & Updates
There Are Reasons To Feel Uneasy About i-SENS' (KOSDAQ:099190) Returns On Capital
Jan 17
What i-SENS, Inc.'s (KOSDAQ:099190) P/S Is Not Telling You
Nov 27Recent updates
There Are Reasons To Feel Uneasy About i-SENS' (KOSDAQ:099190) Returns On Capital
Jan 17What i-SENS, Inc.'s (KOSDAQ:099190) P/S Is Not Telling You
Nov 27i-SENS, Inc. (KOSDAQ:099190) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Aug 05i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings
Mar 27Estimating The Fair Value Of i-SENS, Inc. (KOSDAQ:099190)
May 07Do i-SENS's (KOSDAQ:099190) Earnings Warrant Your Attention?
Mar 29Is i-SENS (KOSDAQ:099190) Using Too Much Debt?
Mar 16Is i-SENS, Inc.'s (KOSDAQ:099190) 0.8% Dividend Worth Your Time?
Mar 01Will i-SENS (KOSDAQ:099190) Multiply In Value Going Forward?
Feb 14
How Much Of i-SENS, Inc. (KOSDAQ:099190) Do Insiders Own?
Jan 31If You Had Bought i-SENS' (KOSDAQ:099190) Shares Five Years Ago You Would Be Down 27%
Jan 18Do Its Financials Have Any Role To Play In Driving i-SENS, Inc.'s (KOSDAQ:099190) Stock Up Recently?
Jan 05Is It Worth Considering i-SENS, Inc. (KOSDAQ:099190) For Its Upcoming Dividend?
Dec 24Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 15i-SENS (KOSDAQ:099190) Could Easily Take On More Debt
Dec 02Does i-SENS, Inc. (KOSDAQ:099190) Have A Place In Your Dividend Portfolio?
Nov 20Shareholder Returns
| A099190 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 2.8% | -0.5% | 0.2% |
| 1Y | -12.1% | 1.3% | -4.9% |
Return vs Industry: A099190 underperformed the KR Medical Equipment industry which returned 1.3% over the past year.
Return vs Market: A099190 underperformed the KR Market which returned -4.9% over the past year.
Price Volatility
| A099190 volatility | |
|---|---|
| A099190 Average Weekly Movement | 8.0% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in KR Market | 13.0% |
| 10% least volatile stocks in KR Market | 3.5% |
Stable Share Price: A099190 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A099190's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 845 | Geun-Sig Cha | www.i-sens.com |
i-SENS, Inc. engages in the development, manufacture, and sale of chemical and biosensors in South Korea and internationally. The company offers blood glucose monitoring devices; diabetes care, acute care, and coagulation care devices; veterinary care devices; and accessory products. It also provides SmartLog, a diabetes management software for mobile and PC.
i-SENS, Inc. Fundamentals Summary
| A099190 fundamental statistics | |
|---|---|
| Market cap | ₩508.54b |
| Earnings (TTM) | -₩1.83b |
| Revenue (TTM) | ₩284.77b |
1.8x
P/S Ratio-280.0x
P/E RatioIs A099190 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A099190 income statement (TTM) | |
|---|---|
| Revenue | ₩284.77b |
| Cost of Revenue | ₩168.91b |
| Gross Profit | ₩115.85b |
| Other Expenses | ₩117.68b |
| Earnings | -₩1.83b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -66.24 |
| Gross Margin | 40.68% |
| Net Profit Margin | -0.64% |
| Debt/Equity Ratio | 54.7% |
How did A099190 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield-151%
Payout RatioDoes A099190 pay a reliable dividends?
See A099190 dividend history and benchmarks| i-SENS dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 25 2025 |
| Days until Ex dividend | 42 days |
| Days until Dividend pay date | 77 days |
Does A099190 pay a reliable dividends?
See A099190 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 10:25 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
i-SENS, Inc. is covered by 17 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ki Kim | Cape Investment & Securities Co., Ltd. |
| Jake Lee | CLSA |
| Jonghyun Park | DAOL Investment & Securities Co., Ltd. |